Renaissance Technologies LLC Sells 19,800 Shares of FONAR Co. (NASDAQ:FONR)

Renaissance Technologies LLC lowered its holdings in FONAR Co. (NASDAQ:FONR) by 5.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 313,716 shares of the medical equipment provider’s stock after selling 19,800 shares during the quarter. Renaissance Technologies LLC owned approximately 4.96% of FONAR worth $4,750,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the business. Money Concepts Capital Corp lifted its holdings in FONAR by 5.9% during the fourth quarter. Money Concepts Capital Corp now owns 401,577 shares of the medical equipment provider’s stock worth $6,080,000 after buying an additional 22,245 shares during the period. Peapod Lane Capital LLC bought a new stake in FONAR during the fourth quarter valued at about $2,159,000. Truffle Hound Capital LLC purchased a new position in FONAR in the fourth quarter valued at about $1,363,000. Linden Thomas Advisory Services LLC raised its holdings in FONAR by 15.1% in the fourth quarter. Linden Thomas Advisory Services LLC now owns 29,236 shares of the medical equipment provider’s stock worth $443,000 after purchasing an additional 3,837 shares in the last quarter. Finally, Empowered Funds LLC boosted its holdings in shares of FONAR by 5.1% in the 4th quarter. Empowered Funds LLC now owns 19,635 shares of the medical equipment provider’s stock valued at $297,000 after buying an additional 945 shares in the last quarter. Hedge funds and other institutional investors own 50.64% of the company’s stock.

FONAR Stock Down 0.7 %

NASDAQ FONR opened at $12.16 on Tuesday. The firm has a market cap of $75.43 million, a PE ratio of 10.57 and a beta of 1.17. FONAR Co. has a 52 week low of $12.06 and a 52 week high of $18.68. The company has a 50 day moving average price of $13.81 and a 200 day moving average price of $14.92.

FONAR (NASDAQ:FONR) last announced its quarterly earnings data on Wednesday, February 19th. The medical equipment provider reported $0.29 earnings per share (EPS) for the quarter. The firm had revenue of $24.95 million during the quarter. FONAR had a return on equity of 4.94% and a net margin of 7.68%.

About FONAR

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.